Shopping Cart
- Remove All
Your shopping cart is currently empty
BMY-14802 hydrochloride (BMS 181100 hydrochloride) is a selective antagonist of σ receptor (IC50 = 112 nM) with antipsychotic effects. BMY-14802 hydrochloride is an agonist of the α1-adrenergic receptor and 5-HT1A.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $30 | In Stock | |
| 10 mg | $48 | In Stock | |
| 25 mg | $102 | In Stock | |
| 50 mg | $173 | In Stock | |
| 100 mg | $260 | In Stock | |
| 200 mg | $369 | In Stock |
| Description | BMY-14802 hydrochloride (BMS 181100 hydrochloride) is a selective antagonist of σ receptor (IC50 = 112 nM) with antipsychotic effects. BMY-14802 hydrochloride is an agonist of the α1-adrenergic receptor and 5-HT1A. |
| Targets&IC50 | σ receptor:112 nM (IC50) |
| In vitro | BMY-14802 hydrochloride shows effects on the firing of 5-HTergic and catecholaminergic neurons and affects behaviors in a 5-HT1A-sensitive manner[3]. |
| In vivo | Intraperitoneal administration of BMY-14802 hydrochloride (5-20 mg/kg) shows anti-dyskinetic efficacy across a 4-fold dose range against L-DOPA-induced dyskinesias without affecting the efficacy of L-DOPA against lesion-induced akinesia. BMY-14802 hydrochloride reduces D1 and D2 receptor agonist-induced dyskinesias[2]. |
| Synonyms | BMY-14802-1, BMY 14802 hydrochloride, BMS 181100 hydrochloride |
| Molecular Weight | 384.85 |
| Formula | C18H23ClF2N4O |
| Cas No. | 105565-55-7 |
| Smiles | Cl.OC(CCCN1CCN(CC1)c1ncc(F)cn1)c1ccc(F)cc1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | H2O: 9.0 mg/mL (23.4 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
H2O
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.